#	Pagina
attuale pagina	/open-h2020/projects/216172/index.html
-1	/open-h2020/per-country/nl/index.html
-2	/open-ted/eng/tender/2024/nuts/pl21/r209-f03/index.html
-3	/open-ted/ita/tender/2022/nuts/pl722/all-all/index.html
-4	/open-ted/ita/tender/2022/nuts/pl823/all-all/index.html
-5	/open-ted/ita/tender/2022/nuts/pl923/all-all/index.html
-6	/open-ted/eng/tender/2024/cpv/50332000/es/all-all/index.html
-7	/open-ted/eng/tender/2024/cpv/50332000/fr/all-all/index.html
-8	/open-ted/eng/tender/2024/cpv/32000000/pl/all-all/index.html
-9	/open-ted/eng/tender/2024/cpv/32000000/es/all-all/index.html
-10	/open-ted/eng/tender/2024/cpv/32000000/hr/all-all/index.html

Opendata, web and dolomites

sFilm-FS SIGNED

Fibrin sealant for anastomotic leaks and haemostasis

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

sFilm-FS project word cloud

Explore the words cloud of the sFilm-FS project. It provides you a very rough idea of what is the project "sFilm-FS" about.

chloride significantly proposing surgery cautery clinical prevention demonstrating calcium shifting absorbable lyophilized suture weeks outcome safety compatible tissue mode medical demonstrates human provides trials ineffective fs gastrointestinal degradable rat permeable glue film components intestinal prognosis combination unlike biological post hemostatic bleeding tested solutions healing intended shorter upscale bio models paradigm surgical sealantium capacity saving manufacturing fluid polymeric time staff soft sfilm action fixing adjunct hemostasis complications ltd leaks standard efforts serve profile absorbed anastomotic impractical sealing perfect body surgeries risks ligature leakage continue fibrinogen contain anastomosis pig commercial primary gmp injured preventing stage contains thrombin efficacy solution

Project "sFilm-FS" data sheet

The following table provides information about the project.

Coordinator	SEALANTIUM MEDICAL LTD Organization address address: 11 AMAL ST AFEK INDUSTRIAL PARK city: ROSH HAAYIN postcode: 4809240 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Israel [IL]
Project website	http://www.sealantium-med.com/
Total cost	2˙003˙388 €
EC max contribution	1˙402˙371 € (70%)
Programme	1. H2020-EU.2.1.4. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
Code Call	H2020-SMEINST-2-2016-2017
Funding Scheme	SME-2
Starting year	2018
Duration (year-month-day)	from 2018-04-01 to 2020-03-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	SEALANTIUM MEDICAL LTD SEALANTIUM MEDICAL LTD Organization address address: 11 AMAL ST AFEK INDUSTRIAL PARK city: ROSH HAAYIN postcode: 4809240 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IL (ROSH HAAYIN)	coordinator	1˙402˙371.00

Map

Project objective

Sealantium Medical Ltd is developing a novel product, sFilm-FS, a bio-compatible bio-absorbable, polymeric film embedded with lyophilized Human Fibrinogen, Human Thrombin and calcium chloride. This novel product aimed to help controlling body fluid leakage in general surgery procedures, proposing its use as an adjunct to hemostasis and/or sealing. sFilm-FS is intended to be used for soft tissue bleeding during surgeries, when control of bleeding by standard surgical methods of hemostasis (suture, ligature, cautery) is ineffective or impractical. sFilm-FS is also intended for use as adjunct to sealing in gastrointestinal anastomosis procedures for prevention of leakage following intestinal anastomosis. sFilm-FS is a combination product based on a degradable, bio-compatible non-permeable polymeric film that contains biological components which serve as a glue fixing the film to its target tissue. Unlike other products which contain similar components, sFilm-FS primary mode of action is based on the sealing capacity of the polymeric film. sFilm-FS was tested in rat and pig models demonstrating high safety profile and effective hemostatic and sealing capabilities. The product was absorbed after two weeks without any side effects allowing perfect healing of the injured tissue. The objective of the project is to continue the development of the product to a stage which demonstrates the safety and efficacy of the product in phase I/II human clinical trials, including GMP manufacturing upscale. sFilm–FS will make surgical procedures shorter by preventing surgical complications, saving time, efforts and risks taken by the medical staff. sFilm-FS will also significantly improve the prognosis and outcome of various surgical procedures by preventing complications related to post-surgical bleeding or anastomotic leakage. The commercial potential in the project is large as it provides better solutions for hemostasis and a paradigm shifting solution for anastomotic leaks.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SFILM-FS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SFILM-FS" are provided by the European Opendata Portal: CORDIS opendata.